Tap into more than 20 years of vital biopharmaceutical industry information

Having trouble viewing images? View in web browser

Dear Colleague- Given the steep decline in third quarter biotech fundraising -- down 48 percent from the same period last year -- it's no surprise that companies are looking for alternatives. And at the recent Foley & Lardner Life Sciences conference in San Diego, a panel debated the merits of considering mergers and acquisitions as a financing strategy rather than an exit strategy. (from Bioworld Today - 11/03/11) Read this story and more in BioWorld Today, the world’s leading biotechnology news and information source for 20 years. Delivered to your desktop every single business day, Bioworld Today gives you all the news you need to know to make good business decisions in the day ahead, you’ll learn: What your competitors are doing ... so you can easily identify opportunities and threats. Where the smart money is going ... where top investors are placing their bets and who is raising funds. The latest technological innovations and discoveries ... to clinical study results across the industry. What the FDA and Congress are up to... so you can prepare for coming changes, and recent approvals. Start your Risk-Free subscription today and save over 50%! Best Regards, Jennifer Boggs Assistant Managing Editor, BioWorld Today    For questions or comments call Customer Service at 404-262-5547 New! Learn More Get Connected!

You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services. If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here. BioSpace 6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S. (888) BIOSPACE